This is a warning from the FDA about Wellbutrin
"... Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of Wellbutrin XL or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Wellbutrin XL is not approved for use in pediatric patients. (See WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use.)"
See: https://www.drugs.com/pro/wellbutrin.html for more information.
The important thing here is to make sure the patient is carefully monitored by family, caregivers and the prescriber.
- Wellbutrin XL Information for Consumers
- Wellbutrin XL Information for Healthcare Professionals (includes dosage details)
- Side Effects of Wellbutrin XL (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 21 Jan 2010 • 1 answer
Posted 1 Jun 2011 • 8 answers
Posted 16 Apr 2012 • 2 answers
Posted 20 Aug 2012 • 2 answers
Posted 9 Jan 2015 • 5 answers